Le Lézard
Classified in: Health
Subjects: SCZ, FVT

New UK App Supports Families Living With Dementia


LONDON, Feb. 26, 2021 /PRNewswire/ -- Following a successful pilot, MOJO ? the online support system for families living with dementia - is set to break nationally, with a Sky TV advertising campaign screening from Monday March 1st.

MOJO (Moments of Joy) connects everybody involved in the care of a loved one, with 12 helpful and imaginative features to reduce stress and find moments of joy even in the face of adversity.

At the Front Line of Dementia Care

Dementia is the UK's biggest cause of death, but unlike many terminal illnesses, it's the wider family who often bear the burden, with very little external support available.

Innovative Support for Hidden Army of Carers

MOJO incorporates a range of creative tools to improve the care experience amongst the wider family, allowing patients to receive the best possible care, but just as importantly; reducing the burden on those around them.

MOJO Manager:

MOJO Mentoring:
Online workshops, forums and 360° specialist advice.

MOJO Monitoring:
Automated family messaging system for wanderers.

Raising the Quality of Care for All Involved

The Alzheimer's Society contend: "Technology should be seen in the context of complementing the care and support provided to an individual to enhance their quality of life."

It's an outlook endorsed by John Thornhill, co-founder of MOJO, "Most of us have seen the effect of dementia on the patient, but MOJO's for the family, whose daily lives are dramatically altered by the responsibility and emotional impact of a loved one's dementia. We believe our ongoing support and technology will make a difficult journey less challenging."

About MOJO:

MOJO (Moments of Joy) is a revolutionary 360° dementia support system for families, providing practical tools to manage treatment and imaginative features to improve the quality of time spent together.

Website: MOJOdementia.org

Instagram: mojodementia

Twitter: mojodementia


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...



News published on and distributed by: